(Q82953963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

meta-analysis

0 references

title

A literature-based meta-analysis taxane-based doublet versus single-agent taxane chemotherapy in patients with advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Hong-Bin Xu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Qing Xu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ling Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

18 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1005-1013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-010-0967-8

18 January 2020

exact match

0 references

cites work

Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).

1 reference

12 December 2020

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.

1 reference

12 December 2020

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

12 December 2020

Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study

1 reference

12 December 2020

Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer

1 reference

12 December 2020

Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?

1 reference

12 December 2020

Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma

1 reference

12 December 2020

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer

1 reference

12 December 2020

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr

1 reference

12 December 2020

Weekly paclitaxel in metastatic breast cancer patients: a phase II study

1 reference

12 December 2020

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies

1 reference

12 December 2020

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study

1 reference

12 December 2020

Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthra

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group

1 reference

12 December 2020

Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group

1 reference

12 December 2020

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer

1 reference

12 December 2020

Interpreting Measures of Treatment Effect in Cancer Clinical Trials

1 reference

12 December 2020

Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer

1 reference

12 December 2020

Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines

1 reference

12 December 2020

Protracted administration of weekly docetaxel in metastatic breast cancer.

1 reference

12 December 2020

Docetaxel: a new active agent in the therapy of metastatic breast cancer.

1 reference

12 December 2020

Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients

1 reference

12 December 2020

Capecitabine plus docetaxel combination therapy

1 reference

12 December 2020

Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer.

1 reference

12 December 2020

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

12 December 2020

Phase II study of weekly docetaxel in patients with metastatic breast cancer

1 reference

12 December 2020

Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer

1 reference

12 December 2020

Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.

1 reference

12 December 2020

Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment

1 reference

12 December 2020

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial

1 reference

12 December 2020

A systematic overview of chemotherapy effects in breast cancer

1 reference

12 December 2020

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

1 reference

12 December 2020

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

1 reference

12 December 2020

Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment

1 reference

12 December 2020

Clinical efficacy of taxane-trastuzumab combination regimens for HER-2-positive metastatic breast cancer

1 reference

12 December 2020

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

12 December 2020

Long-term, weekly one-hour infusion of paclitaxel in patients with metastatic breast cancer: a phase II monoinstitutional study

1 reference

12 December 2020

Docetaxel administered on a weekly basis for metastatic breast cancer

1 reference

12 December 2020

Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial

1 reference

12 December 2020

10.1007/S00432-010-0967-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170550%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference